As of 2025-01-17, the Relative Valuation of Amphastar Pharmaceuticals Inc (AMPH) is 21.27 USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.66 USD, the upside of Amphastar Pharmaceuticals Inc based on Relative Valuation is -40.3%.
The range of the Relative Valuation is 19.50 - 27.13 USD.
| Range | Selected | |
| Trailing P/E multiples | 6.0x - 8.3x | 6.5x |
| Forward P/E multiples | 6.4x - 8.6x | 6.8x |
| Fair Price | 19.50 - 27.13 | 21.27 |
| Upside | -45.3% - -23.9% | -40.3% |
| Date | P/E |
| 2025-01-14 | 11.80 |
| 2025-01-13 | 11.63 |
| 2025-01-10 | 11.15 |
| 2025-01-08 | 11.23 |
| 2025-01-07 | 10.81 |
| 2025-01-06 | 10.87 |
| 2025-01-03 | 11.13 |
| 2025-01-02 | 11.15 |
| 2024-12-31 | 11.39 |
| 2024-12-30 | 11.30 |
| 2024-12-27 | 11.59 |
| 2024-12-26 | 11.71 |
| 2024-12-24 | 11.74 |
| 2024-12-23 | 12.00 |
| 2024-12-20 | 12.00 |
| 2024-12-19 | 12.08 |
| 2024-12-18 | 12.10 |
| 2024-12-17 | 12.53 |
| 2024-12-16 | 12.52 |
| 2024-12-13 | 12.95 |
| 2024-12-12 | 13.65 |
| 2024-12-11 | 13.36 |
| 2024-12-10 | 13.38 |
| 2024-12-09 | 13.44 |
| 2024-12-06 | 13.43 |
| 2024-12-05 | 13.37 |
| 2024-12-04 | 13.59 |
| 2024-12-03 | 13.78 |
| 2024-12-02 | 14.07 |
| 2024-11-29 | 13.86 |
| 2024-11-27 | 13.86 |
| 2024-11-26 | 13.56 |
| 2024-11-25 | 13.69 |
| 2024-11-22 | 13.94 |
| 2024-11-21 | 13.66 |
| 2024-11-20 | 13.52 |
| 2024-11-19 | 13.38 |
| 2024-11-18 | 13.54 |
| 2024-11-15 | 13.68 |
| 2024-11-14 | 13.82 |
| 2024-11-13 | 13.95 |
| 2024-11-12 | 14.63 |
| 2024-11-11 | 14.90 |
| 2024-11-08 | 14.82 |
| 2024-11-07 | 14.13 |
| 2024-11-06 | 16.38 |
| 2024-11-05 | 15.81 |
| 2024-11-04 | 15.51 |
| 2024-11-01 | 15.56 |
| 2024-10-31 | 15.50 |